Join
Live feed
·
PRReleasevia Quantisnow
NeoGenomics Inc. logo

NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer

ByQuantisnow·Wall Street's wire, on your screen.
NEO· NeoGenomics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NEO (NeoGenomics Inc.) and more on Quantisnow.